Cresco Labs Granted Approval for Medical Cannabis Dispensary in Ohio

Cresco Labs (CSE: CL) announced on December 12th that the company has received the first approval of its kind to operate a medical cannabis dispensary in Ohio. The company’s dispensary is located in Wintersville and offers a range of pharmaceutical-grade medical cannabis products for eligible patients in the state that include transdermal patches, oral spays, pills, and more. The Wintersville dispensary offers, along with its premium-quality line of cannabis products, a comprehensive one-on-one consultation session for patients to discuss their symptoms and cannabis use in private.

Chief Executive Officer of Cresco Labs, Charles Bachtell, said: “Receiving the first approval to operate is a major milestone in the transformation of the cannabis program in Ohio. This is also a big step forward for Cresco along our path of unparalleled speed to market, powerful influence in industry development, and proven execution in consumer markets.”

The company also has a 50,000 sq. ft. cultivation facility within the vicinity of the Wintersville dispensary that will eventually supply dispensaries across Ohio with Cresco Labs branded cannabis products.

Risk of Prosecution for Marijuana-Related Companies. If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution. The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana. Many states impose and enforce similar prohibitions. Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”